Published in Int J Pharm on March 22, 2006
Efficient hepatic delivery of drugs: novel strategies and their significance. Biomed Res Int (2013) 0.85
Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs. Int J Nanomedicine (2014) 0.84
Histochemical and biochemical analysis of the size-dependent nanoimmunoresponse in mouse Peyer's patches using fluorescent organosilica particles. Int J Nanomedicine (2012) 0.81
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst (2006) 7.29
Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol (2005) 3.30
Increased emperipolesis in megakaryocytes in a case of idiopathic thrombocytopenic purpura. Indian J Pathol Microbiol (2006) 2.07
Exacerbation of intestinal permeability in rats after a two-hit injury: burn and Enterococcus faecalis infection. Crit Care Med (2004) 1.66
Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis. Gastrointest Endosc (2005) 1.48
Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes. J Natl Cancer Inst (2013) 1.45
High current superconductivity in FeSe0.5Te0.5-coated conductors at 30 tesla. Nat Commun (2013) 1.36
Immunomodulatory effects of aqueous extract of Tridax procumbens in experimental animals. J Ethnopharmacol (2004) 1.14
Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metab Dispos (2004) 1.14
Quantification of κ-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J Allergy Clin Immunol (2011) 1.13
European studies on breast lymphatic mapping. Semin Oncol (2004) 1.12
Nano-vectors for efficient liver specific gene transfer. Int J Nanomedicine (2008) 1.11
Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs. J Control Release (2004) 1.10
Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps. Int J Pharm (2003) 1.09
Microfilariae in bone marrow aspiration smears, correlation with marrow hypoplasia: a report of six cases. Indian J Pathol Microbiol (2006) 1.09
Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine (2006) 1.08
Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine (2008) 1.08
Liposomes modified with cyclic RGD peptide for tumor targeting. J Drug Target (2004) 1.03
Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine. Mol Pharm (2011) 1.02
Strain-driven oxygen deficiency in self-assembled, nanostructured, composite oxide films. ACS Nano (2011) 1.02
Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques. J Pediatr Surg (2007) 1.01
Development of a mouse model for evaluation of small diameter vascular grafts. J Surg Res (2007) 1.00
Staging and surgical approaches in large juvenile angiofibroma--study of 95 cases. Int J Pediatr Otorhinolaryngol (2006) 0.98
TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms. J Immunol (2011) 0.96
Radiology-Pathology Conference: pulmonary hyalinizing granuloma associated with lupus-like anticoagulant and Morvan's Syndrome. Clin Imaging (2007) 0.96
Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine (2008) 0.96
Evaluation of mucoadhesive PLGA microparticles for nasal immunization. AAPS J (2010) 0.96
Engineering nanocolumnar defect configurations for optimized vortex pinning in high temperature superconducting nanocomposite wires. Sci Rep (2013) 0.96
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J Drug Target (2007) 0.95
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int J Pharm (2007) 0.95
Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm (2005) 0.93
European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia. Am J Obstet Gynecol (2004) 0.93
Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clin Exp Nephrol (2013) 0.93
Recent progress in dendrimer-based nanocarriers. Crit Rev Ther Drug Carrier Syst (2006) 0.93
Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate. Sci Pharm (2010) 0.91
Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res (2010) 0.91
A phase II trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women. Breast Cancer Res Treat (2007) 0.89
Multiple intraosseous hemangiomas-investigation and role of N-butylcyanoacrylate in management. Head Neck (2007) 0.89
Dendritic cell-based vaccine research against cancer. Expert Rev Clin Immunol (2014) 0.88
Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. J Control Release (2009) 0.88
Correlation of epicardial fat and anthropometric measurements in Asian-Indians: A community based study. Avicenna J Med (2012) 0.88
Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Int J Pharm (2005) 0.88
Recent advances in search of oral heparin therapeutics. Med Res Rev (2011) 0.88
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. J Immunol (2011) 0.88
Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids (2012) 0.88
Tunable elastin-like polypeptide hollow sphere as a high payload and controlled delivery gene depot. J Control Release (2011) 0.88
Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience. Clin Breast Cancer (2004) 0.88
Feasibility study of aerosolized prostaglandin E1 microspheres as a noninvasive therapy for pulmonary arterial hypertension. J Pharm Sci (2010) 0.87
Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target (2006) 0.87
Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). J Pharm Pharm Sci (2008) 0.87
Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B. J Pharm Pharmacol (2004) 0.86
Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B. J Drug Target (2010) 0.86
Radiology-Pathology Conference: Calcified untreated gastric cancer. Clin Imaging (2004) 0.85
Cerebrospinal fluid otorhinorrhoea due to inner-ear malformations: clinical presentation and new perspectives in management. J Laryngol Otol (2005) 0.85
Histological and immunohistochemical features in fatal acute fulminant hepatitis E. Indian J Pathol Microbiol (2012) 0.85
Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. Int J Pharm (2009) 0.85
Self-assembled ferromagnetic cobalt/yttria-stabilized zirconia nanocomposites for ultrahigh density storage applications. Nanotechnology (2012) 0.85
M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int J Pharm (2009) 0.84
Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis. J Drug Target (2007) 0.84
Lipid drug conjugate (LDC) nanoparticles as autolymphotrophs for oral delivery of methotrexate. J Biomed Nanotechnol (2011) 0.84
Gene expression, biodistribution, and pharmacoscintigraphic evaluation of chondroitin sulfate-PEI nanoconstructs mediated tumor gene therapy. ACS Nano (2009) 0.84
Dieulafoy disease of the stomach presenting as mass lesion--a case report. Indian J Pathol Microbiol (2005) 0.83
Drug delivery strategies for therapy of visceral leishmaniasis. Expert Opin Drug Deliv (2010) 0.83
Evaluation of anti-apoptotic activity of different dietary antioxidants in renal cell carcinoma against hydrogen peroxide. Asian Pac J Trop Biomed (2011) 0.83
Engineered polyallylamine nanoparticles for efficient in vitro transfection. Pharm Res (2007) 0.83
Advances in novel drug delivery strategies for breast cancer therapy. Artif Cells Blood Substit Immobil Biotechnol (2010) 0.83
Teaching neuroImages: Griscelli syndrome and CNS lymphohistiocytosis. Neurology (2014) 0.82
Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection. Mol Pharm (2009) 0.82
Tetanus toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol (2005) 0.82
Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study. Breast Cancer Res Treat (2008) 0.82
Clinical profile and genetic basis of Wiskott-Aldrich syndrome at Chandigarh, North India. Asian Pac J Allergy Immunol (2012) 0.82
Targeted nucleic acid delivery to mitochondria. Curr Gene Ther (2009) 0.82
Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine. J Control Release (2009) 0.81
Development and characterization of site specific target sensitive liposomes for the delivery of thrombolytic agents. Int J Pharm (2010) 0.81
RGD modified albumin nanospheres for tumour vasculature targeting. J Pharm Pharmacol (2011) 0.81
siRNA delivery using nanocarriers - an efficient tool for gene silencing. Curr Gene Ther (2010) 0.81
Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Mol Pharm (2011) 0.81
Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting. J Drug Target (2007) 0.81
Does imaging in sentinel node scintigraphic localization add value to the procedure in patients with breast cancer? Nucl Med Commun (2005) 0.81
Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm (2005) 0.81
Platelets directed liposomes for the delivery of streptokinase: development and characterization. Eur J Pharm Sci (2011) 0.80
Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization. J Drug Target (2011) 0.80
Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin. Drug Dev Ind Pharm (2010) 0.80
Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int J Pharm (2004) 0.80
Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives. Nanomedicine (2009) 0.80
Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis. J Liposome Res (2011) 0.80